Trials / Completed
CompletedNCT03844334
CLinical EValuation of WEB 0.017 Device in Intracranial AneuRysms
CLEVER: CLinical EValuation of WEB 0.017 Device in Intracranial AneuRysms
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 163 (actual)
- Sponsor
- Microvention-Terumo, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The study is an observational, European, multi-center, prospective assessment of the clinical utility of the 0.017 WEB Aneurysm Embolization System in subjects with intracranial aneurysms deemed appropriate for endovascular treatment.
Detailed description
All eligible subjects presenting to the participating Centers will be considered for entry into the study. Up to 160 evaluable subjects meeting the study entry criteria will be enrolled. Subjects will be followed per Institution's standard of care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | WEB Aneurysm Embolization System | Subjects aged ≥ 18 years, but ≤ 80 years requiring treatment for single ruptured or unruptured intracranial aneurysms. |
Timeline
- Start date
- 2019-03-21
- Primary completion
- 2022-08-30
- Completion
- 2022-08-30
- First posted
- 2019-02-18
- Last updated
- 2024-01-24
Locations
4 sites across 3 countries: France, Germany, Hungary
Source: ClinicalTrials.gov record NCT03844334. Inclusion in this directory is not an endorsement.